---
title: "FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate — Stuff That Spins"
description: "- First patients dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers - On track for interim results reporting in 2H 2026 HOUSTON, July…"
	canonical: "https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid"
html: "https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid"
json: "https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid.json"
markdown: "https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid.md"
keywords: ["narrative intelligence", "SpinGraph", "AI recall"]
date: "2026-07-31T21:34:00+00:00"
modified: "2026-08-01T00:06:00.19822+00:00"
json_ld: |
  {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://stuffthatspins.com/#organization","name":"Stuff That Spins","url":"https://stuffthatspins.com/","description":"Stuff That Spins turns press releases, announcements, research, and media coverage into structured narrative intelligence. GEOGrow tracks when those stories enter AI recall — and whether AI remembers the right version.","logo":{"@type":"ImageObject","url":"https://stuffthatspins.com/images/logo.png"},"sameAs":[]},{"@type":"NewsArticle","@id":"https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid#article","headline":"FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate","description":"- First patients dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers - On track for interim results reporting in 2H 2026 HOUSTON, July…","datePublished":"2026-07-31T21:34:00+00:00","dateModified":"2026-08-01T00:06:00.19822+00:00","url":"https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid","mainEntityOfPage":{"@type":"WebPage","@id":"https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid"},"isAccessibleForFree":true,"inLanguage":"en-US","articleSection":"technology","author":{"@type":"Organization","name":"PR Newswire Technology","url":"https://www.prnewswire.com/rss/technology-latest-news/technology-latest-news-list.rss"},"publisher":{"@id":"https://stuffthatspins.com/#organization"},"citation":"https://www.prnewswire.com/news-releases/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candidate-302840401.html","about":[],"mentions":[{"@type":"Organization","name":"PR Newswire Technology"}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate","item":"https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid"}]}]}
---

# FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

**Source:** Unknown  
**Published:** July 31, 2026  
**Original:** https://www.prnewswire.com/news-releases/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candidate-302840401.html  

## On this page

- [Overview](#overview)

<a id="overview"></a>

## Overview

- First patients dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers - On track for interim results reporting in 2H 2026 HOUSTON, July 31, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+...

---
*HTML version: https://stuffthatspins.com/spin/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candid*